TUCSON, Ariz.--(BUSINESS WIRE)--Protein Technologies, Inc. (“PTI” or “the Company”) announced that it has dropped its litigation in the Superior Court of Arizona, County of Pima (Case No. C20150243) against Peptide Solutions, LLC (“PSL”), PSL’s CEO Mahendra Menakuru, and several of PSL’s alleged employees. In return, PSL has agreed to drop its counterclaim suit against PTI and its CEO Nate Cosper. The amicable agreement allows both companies to pursue their respective business interests.
PTI recognizes the leadership and service Mahendra Menakuru provided while serving as the Company’s CEO. During his tenure, PTI experienced significant growth and success, a trend continuing under the Company’s new ownership.
About Peptide Solutions LLC
Peptide Solutions LLC is a distribution partner for Iris Biotech GmbH in North America and is recognized as a leading supplier of reagents used in drug discovery, drug delivery and diagnostics. Please visit www.easypeptide.com.
About Protein Technologies, Inc.
Protein Technologies, Inc. is a leading supplier of quality peptide synthesizers and reagents to universities, biotechnology companies, and pharmaceutical companies. We have built our company on the belief that our products must be the highest possible quality, and we support our products with a dedicated field service team. We are proud of our reputation for reliability and value the trust our customers and partners have placed in PTI. Today we continue to grow and innovate to serve the needs of the peptide synthesis community. To learn more about Protein Technologies, please visit www.ptipep.com.